ACADIAN ASSET MANAGEMENT LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$249
+822.2%
73,363
+2710.8%
0.00%
Q1 2023$27
-98.8%
2,610
-98.6%
0.00%
-100.0%
Q4 2022$2,245
-99.8%
190,584
+235.3%
0.01%
+57.1%
Q3 2022$1,192,000
+1.4%
56,833
+50.2%
0.01%
+16.7%
Q2 2022$1,175,000
-48.4%
37,839
-31.8%
0.01%
-33.3%
Q1 2022$2,278,000
-50.3%
55,490
-47.4%
0.01%
-47.1%
Q4 2021$4,588,000
-37.1%
105,550
-27.5%
0.02%
-39.3%
Q3 2021$7,291,000
-32.5%
145,634
-15.1%
0.03%
-31.7%
Q2 2021$10,800,000
+7.6%
171,445
+58.7%
0.04%
+5.1%
Q1 2021$10,036,000
-22.2%
108,011
-25.0%
0.04%
-22.0%
Q4 2020$12,903,000
+8.5%
144,000
+25.1%
0.05%0.0%
Q3 2020$11,894,000
+32.8%
115,103
+1.6%
0.05%
+28.2%
Q2 2020$8,956,000
-44.6%
113,257
-62.2%
0.04%
-46.6%
Q4 2019$16,168,000
-35.7%
299,673
-42.4%
0.07%
-39.7%
Q2 2019$25,135,000
-30.8%
520,302
-27.6%
0.12%
-22.4%
Q1 2019$36,322,000
-34.3%
718,984
-22.9%
0.16%
-43.1%
Q4 2018$55,291,000
-33.7%
932,704
-26.4%
0.27%
-20.6%
Q3 2018$83,442,000
+8.8%
1,267,510
-16.6%
0.34%
+3.9%
Q2 2018$76,712,000
-14.3%
1,519,346
-10.6%
0.33%
-14.2%
Q1 2018$89,495,000
+33.2%
1,699,823
+17.6%
0.39%
+33.0%
Q4 2017$67,165,000
+22.0%
1,445,412
+6.2%
0.29%
+19.8%
Q3 2017$55,043,000
+31.3%
1,360,699
+10.0%
0.24%
+27.9%
Q2 2017$41,935,000
+3.1%
1,236,678
-11.7%
0.19%
+2.2%
Q1 2017$40,658,000
-10.4%
1,400,091
+1.4%
0.19%
-15.5%
Q4 2016$45,366,000
-10.3%
1,381,352
-13.9%
0.22%
-12.0%
Q3 2016$50,573,000
+13.3%
1,604,001
+1.1%
0.25%
+9.6%
Q2 2016$44,634,000
-22.6%
1,587,2030.0%0.23%
-21.6%
Q1 2016$57,694,000
+57.9%
1,587,203
+73.8%
0.29%
+52.4%
Q4 2015$36,537,000
+198.7%
913,260
+112.7%
0.19%
+185.1%
Q3 2015$12,231,000
-4.2%
429,324
+10.8%
0.07%
+8.1%
Q2 2015$12,763,000
+26.0%
387,409
+10.0%
0.06%
+31.9%
Q1 2015$10,130,000
+22.8%
352,145
+16.2%
0.05%
+27.0%
Q4 2014$8,251,000
-16.3%
302,989
-34.5%
0.04%
-22.9%
Q3 2014$9,857,000
-25.0%
462,357
-21.0%
0.05%
-25.0%
Q2 2014$13,150,000
+212.7%
585,372
+251.7%
0.06%
+190.9%
Q1 2014$4,205,000
+69.3%
166,434
+54.0%
0.02%
+57.1%
Q4 2013$2,484,000
+9.5%
108,109
-9.2%
0.01%
-6.7%
Q3 2013$2,269,000119,0460.02%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders